Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Risk Myelodysplastic Syndrome (LR-MDS)”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT07008820
What this trial is testing

Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan

Who this might be right for
Myelodysplastic Syndrome (MDS)
Bristol-Myers Squibb 56
Early research (Phase 1)Not Yet RecruitingNCT07753148
What this trial is testing

Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic Syndrome With SF3B1 Mutation

Who this might be right for
Clonal Cytopenia of Undetermined Significance (CCUS)Low-Risk Myelodysplastic Syndrome (LR-MDS)
Regeneron Pharmaceuticals 52
Large-scale testing (Phase 3)Active Not RecruitingNCT06045689
What this trial is testing

Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Looking for participantsNCT05384691
What this trial is testing

Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions

Who this might be right for
Myelodysplastic SyndromesAnemia
University of Leipzig 213
Testing effectiveness (Phase 2)Looking for participantsNCT06063486
What this trial is testing

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceEssential ThrombocythemiaMyelodysplastic Syndrome+2 more
University of Southern California 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07722988
What this trial is testing

Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Kyntra Bio 201
Testing effectiveness (Phase 2)Looking for participantsNCT05308264
What this trial is testing

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Who this might be right for
Low Risk Myelodysplastic Syndromes
Rigel Pharmaceuticals 86
Testing effectiveness (Phase 2)Ended earlyNCT05237713
What this trial is testing

Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients

Who this might be right for
AnemiaMyelodysplastic Syndromes
University of Leipzig 10